Muprivex
Brand Name: Muprivex
Generic Name: Mupirocin
Active
Registration Number
DR-XY48722
Dosage Form
Ointment
Issuance Date
February 2, 2024
Expiry Date
May 26, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength20MG/G (2% w/w)
PackagingLaminated Aluminum Tube 5 g and 10 g (Box of 1's)
Classification
C
Classification
Over-the-Counter (OTC)
P
Pharmacologic
Antibacterial (Antibiotic for Topical Use)
A
Application
Initial (OTC) Correction]
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
MupirocinActive
Monograph: Mupirocin